ARBUTUS BIOPHARMA CORP (ABUS) Stock Price, Quote, News and Overview

What is the stock price of ARBUTUS BIOPHARMA CORP today?

The current stock price of ABUS is 3.32 USD. The price decreased by -5.41% in the last trading session.

What is the ticker symbol for ARBUTUS BIOPHARMA CORP stock?

The exchange symbol of ARBUTUS BIOPHARMA CORP is ABUS and it is listed on the Nasdaq exchange.

On which exchange is ABUS stock listed?

ABUS stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for ARBUTUS BIOPHARMA CORP stock?

10 analysts have analysed ABUS and the average price target is 5.36 USD. This implies a price increase of 61.3% is expected in the next year compared to the current price of 3.32. Check the ARBUTUS BIOPHARMA CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is ARBUTUS BIOPHARMA CORP worth?

ARBUTUS BIOPHARMA CORP (ABUS) has a market capitalization of 635.71M USD. This makes ABUS a Small Cap stock.

How many employees does ARBUTUS BIOPHARMA CORP have?

ARBUTUS BIOPHARMA CORP (ABUS) currently has 44 employees.

What are the support and resistance levels for ARBUTUS BIOPHARMA CORP (ABUS) stock?

ARBUTUS BIOPHARMA CORP (ABUS) has a support level at 3.31 and a resistance level at 3.59. Check the full technical report for a detailed analysis of ABUS support and resistance levels.

Is ARBUTUS BIOPHARMA CORP (ABUS) expected to grow?

The Revenue of ARBUTUS BIOPHARMA CORP (ABUS) is expected to grow by 12.12% in the next year. Check the estimates tab for more information on the ABUS EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy ARBUTUS BIOPHARMA CORP (ABUS) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of ABUS, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of ABUS, evaluating the profitability, health, valuation and growth aspects
• ARBUTUS BIOPHARMA CORP (ABUS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• ARBUTUS BIOPHARMA CORP (ABUS) Sales and EPS estimates to see what analysts future expectations are.
• ARBUTUS BIOPHARMA CORP (ABUS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• ARBUTUS BIOPHARMA CORP (ABUS) Insider and Institutional Ownership to learn about the owners and their transactions.
• ARBUTUS BIOPHARMA CORP (ABUS) Stock Chart to make your own analysis
• ARBUTUS BIOPHARMA CORP (ABUS) Latest news and press-releases to stay up to date.

Does ARBUTUS BIOPHARMA CORP (ABUS) stock pay dividends?

ABUS does not pay a dividend.

When does ARBUTUS BIOPHARMA CORP (ABUS) report earnings?

ARBUTUS BIOPHARMA CORP (ABUS) will report earnings on 2025-07-30, before the market open.

What is the Price/Earnings (PE) ratio of ARBUTUS BIOPHARMA CORP (ABUS)?

ARBUTUS BIOPHARMA CORP (ABUS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.37).

What is the Short Interest ratio of ARBUTUS BIOPHARMA CORP (ABUS) stock?

The outstanding short interest for ARBUTUS BIOPHARMA CORP (ABUS) is 7.39% of its float. Check the ownership tab for more information on the ABUS short interest.

ChartMill assigns a fundamental rating of 4 / 10 to ABUS. ABUS has a great financial health rating, but its profitability evaluates not so good.

Over the last trailing twelve months ABUS reported a non-GAAP Earnings per Share(EPS) of -0.37. The EPS increased by 15.91% compared to the year before.

ChartMill assigns a Buy % Consensus number of 82% to ABUS. The Buy consensus is the average rating of analysts ratings from 10 analysts.

For the next year, analysts expect an EPS growth of 41.01% and a revenue growth 12.12% for ABUS